Johnson & Johnson Considering Sale of Stroke Product Line for Over $1 Billion
February 12, 2025 - 22:23
Johnson & Johnson is reportedly exploring the sale of its Cerenovus line, which specializes in stroke-related medical products. According to sources familiar with the situation, the company has engaged in preliminary discussions with potential buyers, signaling a strategic move within its broader business framework.
The Cerenovus product line includes devices designed to treat ischemic strokes, which are caused by blockages in blood vessels supplying blood to the brain. This segment has become increasingly significant as the demand for innovative stroke treatment solutions rises.
While the exact valuation remains uncertain, reports suggest that Johnson & Johnson aims to secure more than $1 billion from the sale. This potential divestiture aligns with the company's ongoing efforts to streamline its operations and focus on core areas of growth. As the healthcare landscape evolves, such strategic decisions could reshape the company's portfolio and enhance its market position in the medical device sector.
MORE NEWS
February 24, 2026 - 03:50
The Impact of Sweeping Tariffs on American Businesses and ConsumersOver the past year, the United States has enacted a series of substantial tariffs on a vast array of imported goods. This policy shift, aimed at reducing trade imbalances and strengthening domestic...
February 23, 2026 - 04:45
Dating has been hard as an American living in another countryFor many, the idea of dating in Paris conjures images of romantic strolls along the Seine. However, the reality for Americans living in the City of Light can be a challenging journey through a maze...
February 22, 2026 - 06:03
Local Business Spotlight: Drury Lane BooksNestled in downtown Grand Marais, Drury Lane Books stands as a cherished haven for bibliophiles and a cornerstone of the local community. More than just a store, it serves as a quiet refuge where...
February 21, 2026 - 03:03
CFO whose business fell 10% from tariffs cheers Supreme Court ruling: ‘No single person should have unilateral authority over tariffs’Matt Totsch, Chief Financial Officer of the building materials manufacturer Trim-Tex, is celebrating a recent Supreme Court decision that challenges unilateral presidential authority to impose...